4.7 (587) · $ 8.50 · In stock
Medicare Part D, the outpatient prescription drug benefit for Medicare beneficiaries, provides coverage above a catastrophic threshold for high out-of-pocket drug costs, but there is no cap on total out-of-pocket drug costs that beneficiaries pay each year. Recent legislative proposals would add a cap on out-of-pocket spending under Part D. This analysis focuses on the potential impact of different out-of-pocket spending caps in terms of how many beneficiaries would be affected and how much they could save.
Medicare Part D in 2016 and Trends over Time - Section 1: Part D
The Second Decade of Medicare Part D: Time to Modernize? - The
Best Rated Medicare Part D Plans for 2024
Understanding the Health Provisions in the Inflation Reduction Act and Their Implications for Oncology Care - The ASCO Post
Medicare Begins to Rein In Drug Costs for Older Americans - The
Using External Reference Pricing In Medicare Part D To Reduce Drug
Changes to Medicare Part D in 2024 and 2025 - Patient Empowerment
The Inflation Reduction Act Will Save Families Thousands of Dollars - Center for American Progress
Medicare (United States) - Wikipedia
Underrepresented Groups Would Save with Part D OOP Cap
The Inflation Reduction Act Will Save Families Thousands of Dollars - Center for American Progress